ACCELERATED PUBLICATION
Mechanism of Calcium-independent Synaptotagmin Binding to Target SNAREs*

Colin Rickman and Bazbek DavletovDagger

From the Medical Research Council Laboratory of Molecular Biology, Hills Road, Cambridge CB2 2QH, United Kingdom

Received for publication, December 13, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Synaptic vesicle exocytosis requires three SNARE (soluble N-ethylmaleimide-sensitive-factor attachment protein receptor) proteins: syntaxin and SNAP-25 on the plasma membrane (t-SNAREs) and synaptobrevin/VAMP on the synaptic vesicles (v-SNARE). Vesicular synaptotagmin 1 is essential for fast synchronous SNARE-mediated exocytosis and interacts with the SNAREs in brain material. To uncover the step at which synaptotagmin becomes linked to the three SNAREs, we purified all four proteins from brain membranes and analyzed their interactions. Our study reveals that, in the absence of calcium, native synaptotagmin 1 binds the t-SNARE heterodimer, formed from syntaxin and SNAP-25. This interaction is both stoichiometric and of high affinity. Synaptotagmin contains two divergent but conserved C2 domains that can act independently in calcium-triggered phospholipid binding. We now show that both C2 domains are strictly required for the calcium-independent interaction with the t-SNARE heterodimer, indicating that the double C2 domain structure of synaptotagmin may have evolved to acquire a function beyond calcium/phospholipid binding.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Syntaxin, SNAP-25,1 and synaptobrevin, also known as VAMP, are members of a large family of SNARE proteins that likely execute fusion in all intracellular compartments (1-3). Whereas most intracellular membrane fusion reactions are constitutive, neurotransmission relies on the coupling of neurotransmitter release to calcium influx into the nerve terminal (4). On calcium entry, a proportion of synaptic vesicles fuse with the presynaptic membrane and release neurotransmitter with a delay of less than 1 ms (5). The synchronization of neuronal exocytosis to calcium entry has been attributed to synaptotagmin, a major synaptic vesicle protein (6, 7). Synaptotagmin contains two calcium-binding C2 domains and is proposed to be a calcium sensor in neuronal exocytosis (8, 9).

Despite identification of the major players involved in neurotransmitter release, the molecular mechanisms responsible for the tight coupling between calcium influx and synaptic vesicle exocytosis are still under debate (10, 11). Previous biochemical studies implicated calcium-dependent binding of synaptotagmin to either syntaxin or SNAP-25 in vesicular exocytosis (12-14). However, the short delay between calcium influx and the fusion of synaptic vesicles suggests that synaptotagmin is linked to the fusion machinery prior to calcium influx into the nerve terminal. Indeed, synaptotagmin, in the absence of calcium, co-purifies with the SNARE complexes from brain material as demonstrated using anti-syntaxin immunoprecipitation and alpha -SNAP affinity chromatography (15, 16).

The calcium-independent molecular link between the calcium sensor and the SNARE fusion machinery is not well understood, and the previous studies using recombinant protein fragments yielded conflicting results (reviewed in Refs. 10 and 11). Therefore, we investigated this link using, for the first time, highly purified brain synaptotagmin and SNARE proteins as a starting point. We now demonstrate that brain-purified t-SNAREs, syntaxin and SNAP-25, form a stable heterodimer that can bind native synaptotagmin in the absence of calcium. Since this interaction can be reproduced using the recombinant cytoplasmic domain of synaptotagmin 1, we were able to address the requirement for C2 domains in this binding. Our results show that the calcium-independent binding of synaptotagmin to the t-SNARE heterodimer requires the double C2 domain structure.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Isolation of SNARE Proteins and Synaptotagmin-- All procedures were carried out at 4 °C. 1 mg of anti-SNAP-25 SMI 81 monoclonal antibody (Sternberger Monoclonals) was covalently coupled to 1 ml of CNBr-activated Sepharose-4B (Amersham Biosciences) according to the manufacturer's instructions. 3.5 g of bovine cerebral cortex was homogenized in 50 ml of phosphate-buffered saline (PBS) containing 2 mM EDTA, and the membrane material was collected by centrifugation at 12,000 × g. Pelleted membranes were solubilized in PBS in the presence of 2% (v/v) Triton X-100 and Complete protease inhibitor mixture (Roche Molecular Biochemicals). The lysate was cleared by centrifugation and batch-incubated with the anti-SNAP-25-Sepharose for 2 h. Total protein in the loading material was estimated by BCA protein determination kit (Pierce) to be 250 mg. The beads were then washed in a column with 30 ml of 100 mM NaCl, 2 mM EDTA, 20 mM Hepes, pH 7.0, 0.1% Triton X-100 (buffer A) followed by 10 ml of buffer A adjusted to 0.3 M NaCl. Bound proteins (1 mg in total) were eluted with 10 ml of buffer A adjusted to 0.6 M NaCl followed by 10 ml of 0.25 M NaCl, 0.2 mM EGTA, 0.1% Triton X-100, 20 mM glycine HCl buffer, pH 2.5. Synaptotagmin in the 0.6 M NaCl eluate was further purified by a heparin affinity chromatography. Brain monomeric SNARE proteins were prepared as described previously (25). Plasmids encoding glutathione S-transferase (GST) fusion proteins of syntaxin 1A (amino acids 1-265), synaptobrevin 2 (amino acids 1-96), the wild-type cytoplasmic part C2AB of synaptotagmin 1 (amino acids 96-421), mutated C2AB G374D, C2A domain (amino acids 95-265), and C2B domain (amino acids 248-421) were described previously (17-19). Recombinant proteins, purified on glutathione-Sepharose beads, were released from GST, where necessary, by thrombin cleavage.

Re-assembly of SNARE and Synaptotagmin Complexes and Their Quantification-- SNARE proteins or synaptotagmin (~2 µg each) attached to appropriate Sepharose beads (~15 µl bed volume) were incubated for 30 min at room temperature in 200 µl buffer A with 1-2 µM protein to be tested for binding. Beads were washed three times by low speed centrifugation with 1 ml of buffer A, and bound protein was eluted in sample buffer followed by SDS-PAGE in 12% Ready gels (Bio-Rad) and Coomassie staining. For determination of the stoichiometry of binding, proteins bound to the beads were eluted into sample buffer and separated by SDS-PAGE. Gels were stained with Sypro Orange (Bio-Rad) according to the manufacturer's intstructions. Fluorescent protein bands were imaged using a CCD camera, and the intensity of fluorescence was analyzed using ImageQuant software (Amersham Biosciences). To calculate the molar ratio of interacting proteins, the measured values of bound fluorescence for each band were divided by their corresponding molecular masses. To estimate the binding affinity of syntaxin/SNAP-25 to synaptotagmin, glutathione-Sepharose beads containing 50 ng of GST-C2AB were incubated for 30 min with 2 µM brain-purified SNAP-25 and increasing concentration of brain-purified syntaxin (0-1.7 µM) in a reaction volume of 100 µl. The beads were washed three times with 1 ml of buffer A, and bound protein was eluted into sample buffer. Bound SNAP-25 was analyzed by SDS-PAGE and Western immunoblotting using a monoclonal anti-SNAP-25 antibody and enhanced chemilumenescent kit West Dura (Pierce). A series of exposures of the chemilumenescent bands were taken to ensure that saturation of the Super RX x-ray film (Fuji Photo) was not reached. The film was scanned on a trans-illumination densitometer, and the intensities of bands were analyzed using the ImageQuant software. The density values were plotted as a dose-response relationship using Prism (GraphPad Software).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We used a preparative anti-SNAP-25 immunoaffinity chromatography to test an interaction of synaptotagmin with the SNAREs in the absence of calcium in native material, namely bovine brain membranes. The brain membrane extract was incubated with an anti-SNAP-25 antibody covalently attached to Sepharose beads in the presence of 2 mM EDTA, a calcium-chelating agent. Following a two-step elution, bound proteins were analyzed by SDS-gel electrophoresis and Coomassie staining (Fig. 1, left panel). For identification of protein bands both Western immunoblotting and mass spectrometry were used (Fig. 1 and data not shown). The 0.6 M NaCl eluate contained synaptotagmin 1, whereas the pH 2.5 eluate contained the three SNAREs and complexin. To determine the specificity of protein isolation on the anti-SNAP-25 column, we performed a chromatography of the brain extract using control beads with covalently attached bovine serum albumin. Myelin basic protein, but not synaptotagmin nor complexin, bound to the control beads (Fig. 1, right panel). Thus, synaptotagmin and complexin are the major proteins that specifically co-purify with the SNARE complexes, in the absence of divalent cations.


View larger version (52K):
[in this window]
[in a new window]
 
Fig. 1.   Synaptotagmin 1 interacts with SNARE complexes in brain in the absence of calcium. 250 mg of Triton X-100-solubilized brain membrane protein (Load) was incubated with anti-SNAP-25-Sepharose beads (left panel) or control BSA-Sepharose beads (right panel). Following a wash in 0.3 M NaCl (Wash), synaptotagmin (Syt) was eluted with 0.6 M NaCl, whereas syntaxin (Syx), SNAP-25, synaptobrevin (Syb), and complexin (Cxn) were eluted using 20 mM glycine HCl, pH 2.5. Chromatography samples, after boiling in SDS-containing loading buffer, were analyzed by SDS-PAGE followed by Coomassie staining. The major band at 65 kDa was identified by MALDI-TOF mass spectrometry as synaptotagmin 1. Western immunoblot for synaptotagmin 1 (lower panel) was performed using a monoclonal antibody (clone 41.1) and an enhanced chemiluminescence technique. Myelin basic protein (MBP) non-specifically interacted with both types of Sepharose. The positions of Precision molecular weight markers (Bio-Rad) are shown on the left.

Several scenarios can account for the co-purification of synaptotagmin with the SNAREs on the anti-SNAP-25 column. Synaptotagmin may interact with monomeric SNAP-25 as suggested previously (20). Alternatively, it may interact with SNARE complexes containing SNAP-25. Thus, we investigated whether SNAP-25 can form stable complexes with syntaxin and synaptobrevin. Fig. 2A shows that SNAP-25, prebound to anti-SNAP-25-Sepharose beads, was able to bind syntaxin and could only bind synaptobrevin when syntaxin was present. Therefore, co-purification of synaptotagmin 1 during anti-SNAP-25 chromatography may be due to its interaction with either SNAP-25 alone and/or the t-SNARE heterodimer and/or the full ternary SNARE complex. To distinguish between these possibilities, we prepared anti-SNAP-25-Sepharose beads carrying either SNAP-25 alone, the t-SNARE heterodimer, or the full SNARE complex and incubated them with brain-purified synaptotagmin 1. After washing, bound protein was analyzed by SDS-PAGE and Coomassie staining (Fig. 2B). The native synaptotagmin, in the absence of calcium, was able to interact with the t-SNARE heterodimer and the ternary SNARE complex, but not with SNAP-25 alone. We conclude that, in the case of brain-purified proteins, the interaction of synaptotagmin with the native or re-assembled SNARE complexes does not require calcium.


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 2.   Brain-purified synaptotagmin 1 binds the t-SNARE heterodimer in the absence of calcium. A, beads with immobilized SNAP-25 were mixed with input material composed of syntaxin and synaptobrevin individually or together. After extensive washing, proteins bound to the beads were eluted into sample buffer. Boiled samples of input (left panel) and bound (right panel) material were analyzed by SDS-PAGE followed by Coomassie staining. SNAP-25 binds syntaxin alone and synaptobrevin only in the presence of syntaxin. B, anti-SNAP-25 beads with prebound ternary SNARE complex, SNAP-25 alone, or the t-SNARE heterodimer were then incubated with brain purified synaptotagmin 1 for 30 min at room temperature in 2 mM EDTA. After washing, boiled samples of the input and bound proteins were analyzed by SDS-PAGE followed by Coomassie staining. Synaptotagmin 1 binds the ternary SNARE complex and the t-SNARE heterodimer in the absence of calcium.

Since in the SNARE assembly pathway the stable t-SNARE heterodimer exists in brain (21) and precedes the ternary SNARE complex (22), we analyzed in more detail the calcium-independent interaction of synaptotagmin with syntaxin and SNAP-25. First, we tested whether the recombinant cytoplasmic part of synaptotagmin 1 (C2AB, amino acids 96-421) has the ability to bind monomeric SNAREs and/or the t-SNARE heterodimer. In the absence of calcium, the cytoplasmic part of synaptotagmin bound the t-SNARE heterodimer, but none of the monomeric SNAREs (Fig. 3A). To determine the binding efficiency we analyzed the stoichiometry of interaction using fluorescent Sypro Orange staining, which labels proteins quantitatively (23). The two t-SNAREs were incubated with the immobilized cytoplasmic domain of synaptotagmin and, after washing, the bound protein was analyzed by SDS-PAGE followed by Sypro Orange staining. Quantification of bound dye in relation to the molecular masses of the bound proteins yielded a molar ratio of 1:1.28:1.2 for synaptotagmin, syntaxin, and SNAP-25, respectively (Fig. 3B). We conclude that the binding of GST-C2AB to the t-SNAREs is approximately equimolar. We next investigated the dependence for binding of SNAP-25 to synaptotagmin as a function of syntaxin concentration. Syntaxin at concentrations ranging from 27 nM to 1.7 µM was added to GST-C2AB beads in the presence of a constant concentration of SNAP-25. Syntaxin promoted binding of SNAP-25 to synaptotagmin at concentrations above 100 nM with the half-maximal binding measured at 290 nM (Fig. 3C).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 3.   The cytoplasmic part of synaptotagmin 1 binds stoichiometrically and with high affinity to the t-SNARE heterodimer. A, input consisting of either monomeric SNAREs or the t-SNARE heterodimer (left panel) was incubated for 30 min with immobilized GST-C2AB in the presence of 2 mM EDTA. After extensive washing the bound proteins (right panel) were analyzed by SDS-PAGE followed by Coomassie staining. The cytoplasmic part of synaptotagmin (GST-C2AB) binds the t-SNARE heterodimer in the absence of calcium. B, GST-C2AB immobilized on beads was incubated with syntaxin and SNAP-25 in the presence of 2 mM EDTA. After washing, the bound material was analyzed by SDS-PAGE followed by Sypro Orange staining. Staining density was converted to molar ratios, demonstrating stoichiometric binding of the t-SNARE heterodimer to the cytoplasmic part of synaptotagmin. C, binding of SNAP-25 to GST-C2AB beads as a function of syntaxin concentration. SNAP-25 (2 µM) was incubated with GST-C2AB (50 ng) immobilized on beads in the presence of varying concentrations of syntaxin (0-1.7 µM). Bound SNAP-25 was analyzed by Western immunoblotting and densitometric analysis. Fitting a dose-response relationship yielded an EC50 for syntaxin-dependent SNAP-25 binding of 290 nM.

Two versions of the synaptotagmin cytoplasmic domain were cloned, one with a mutation of glycine to aspartic acid at residue 374 in the second C2 domain (C2B) (19, 24). This mutation has been shown to adversely effect folding of the C2B beta -strand barrel structure (25). Fig. 4B shows that the t-SNARE heterodimer bound the wild-type cytoplasmic part, but not its mutated version, suggesting that either both C2 domains or the C2B domain alone are required for this interaction. We therefore analyzed whether, in the absence of calcium, individual C2 domains from the wild-type cytoplasmic part can be the t-SNARE heterodimer. Neither of the individual C2 domains was able to bind the t-SNARE heterodimer, but when linked together they exhibited efficient binding (Fig. 4C).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 4.   A requirement for both C2 domains of synaptotagmin for interaction with the t-SNARE heterodimer. A, domain structure of full-length native synaptotagmin and recombinant fragments used for binding studies. B, GST-C2AB carrying a mutation in its C2B domain does not bind the t-SNARE heterodimer. Immobilized GST-C2AB (wild-type or G374D mutated version) was incubated with the t-SNARE heterodimer in the absence of calcium. The asterisk indicates a breakdown product of the mutated GST-C2AB present on both the original beads (left panel) and after incubation with syntaxin and SNAP-25 (right panel). Input and bound proteins were analyzed by SDS-PAGE followed by Coomassie staining. C, the input of t-SNARE heterodimer was incubated with immobilized recombinant fragments of synaptotagmin GST-C2A, GST-C2B, or GST-C2AB in 2 mM EDTA. Only the cytoplasmic part containing both C2 domains (C2AB) was able to bind the t-SNARE heterodimer.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Synaptotagmin, the proposed calcium sensor, is essential for coupling the calcium signal to the synaptic vesicle exocytosis (6, 7). In this study we addressed whether such coupling could be due to a physical link between the calcium sensor and the SNARE fusion machinery. We demonstrated by an anti-SNAP-25 immunoaffinity approach that synaptotagmin, in the absence of calcium, can specifically co-purify with the SNAREs from bovine brain detergent extract (Fig. 1). This is in agreement with the previously observed calcium-independent association of synaptotagmin with the SNARE complexes by anti-syntaxin immunoprecipitation from rat brain (15) and by alpha -SNAP affinity chromatography from bovine brain (16). Moreover, syntaxin itself was originally identified as a protein that co-purifies in the absence of calcium with synaptotagmin by anti-synaptotagmin immunoisolation (26). It is notable that further studies, using recombinant syntaxin, questioned an efficient calcium-independent link between synaptotagmin and syntaxin (12, 13), suggesting that either syntaxin may require other proteins for this interaction or the bacterially expressed SNARE fragments are deficient in some of their properties (11).

To address the molecular basis for the calcium-independent association between the SNAREs and synaptotagmin, we used for the first time brain-purified SNARE proteins and native synaptotagmin in parallel with its truncated versions. Three SNARE proteins, when mixed, formed the ternary complex that can bind synaptotagmin (Fig. 2). We further analyzed the possible calcium-independent association of synaptotagmin with the SNAREs in the stages preceding the ternary SNARE complex. Syntaxin and SNAP-25 can form a stable intermediate on the pathway from the three monomeric SNAREs to their ternary complex, consistent with a central role for the t-SNARE heterodimer in SNARE complex formation (Fig. 2A) (21, 22). Remarkably, the t-SNARE heterodimer, but not monomeric SNAREs, was able to bind synaptotagmin with high affinity and stoichiometrically in the absence of calcium (Fig. 3). Association of syntaxin with SNAP-25 at the release sites in the presynaptic membrane, therefore, may be an important step for further engagement of both vesicular synaptotagmin and synaptobrevin. As synaptobrevin is potently inhibited on synaptic vesicle membrane (27), synaptotagmin interaction with the t-SNARE heterodimer may precede and facilitate further engagement of synaptobrevin into the fusion-competent SNARE complex.

A quantitive electron microscopy study of synapse morphology in the absence of synaptotagmin revealed that synaptic vesicles are no longer maintained in close proximity to the presynaptic membrane (28). One attractive mechanism for this phenomenon was put forward, whereby synaptotagmin interacts in the absence of calcium with monomeric SNAP-25 to position the vesicles at the release sites (20). However, this hypothesis is inconsistent with the observation that SNAP-25 is found throughout the plasma membrane (21, 29). In addition, further studies could only detect binding of synaptotagmin to SNAP-25 by Western immunoblotting (14, 30), suggesting a low affinity interaction. In our study monomeric SNAP-25 did not interact with synaptotagmin (Figs. 2 and 3) probably because we used brain-purified protein that may differ in its properties compared with SNAP-25 expressed in bacteria. Importantly, genetic manipulations of both syntaxin and SNAP-25 result in the uncoupling of calcium entry and exocytosis (14, 31), indicating that both t-SNAREs participate in linking synaptotagmin to the fusion machinery.

Finally, our data shows that both C2A and C2B domains of synaptotagmin 1 are required for the calcium-independent interaction with the t-SNARE heterodimer (Fig. 4). Phospholipases, protein kinases, and other enzymes contain a single copy of the C2 domain that is known to drive their calcium-dependent translocation to cellular membranes (32). A number of trafficking proteins, on the other hand, e.g. DOC2, Munc13, rabphilin, the large family of synaptotagmins and others, have a closely aligned double C2 domain structure (33, 34). One remarkable property of these C2 domains is that they often lack calcium binding aspartate residues and are not able to bind phospholipid membranes in response to calcium (12, 34). Intriguingly, knock-in studies of synaptotagmin 1 itself demonstrated that calcium binding is dispensable for the C2A but not the C2B domain (35-37). These observations point to a functional importance of the double C2 domain structure that cannot solely be explained on the basis of the calcium-dependent properties of each domain (37). Indeed, our study provides a novel explanation for the functional importance of the double C2 domain structure: two C2 domains of synaptotagmin act together to bind, with high affinity and in the absence of calcium, t-SNARE heterodimers in the target membranes.

    ACKNOWLEDGEMENTS

We are grateful to Giampietro Schiavo and Ed Chapman for synaptotagmin plasmids. We thank Sew Peak-Chew for MALDI-TOF mass spectrometry protein identification.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 44-1223-402071; Fax: 44-1223-402310; E-mail: baz@mrc-lmb.cam.ac.uk.

Published, JBC Papers in Press, December 20, 2002, DOI 10.1074/jbc.C200692200

    ABBREVIATIONS

The abbreviations used are: SNAP-25, synaptosome-associated protein of 25 kDa; SNARE, soluble N-ethylmaleimide-sensitive factor attachment protein receptor; GST, glutathione S-transferase; PBS, phosphate-buffered saline; BSA, bovine serum albumin; MALDI-TOF, matrix-assisted laser desorption ionization time-of-flight.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Jahn, R., and Sudhof, T. C. (1999) Annu. Rev. Biochem. 68, 863-911[CrossRef][Medline] [Order article via Infotrieve]
2. Chen, Y. A., and Scheller, R. H. (2001) Nat. Rev. Mol. Cell. Biol. 2, 98-106[CrossRef][Medline] [Order article via Infotrieve]
3. Sollner, T., Whiteheart, S. W., Brunner, M., Erdjument-Bromage, H., Geromanos, S., Tempst, P., and Rothman, J. E. (1993) Nature 362, 318-324[CrossRef][Medline] [Order article via Infotrieve]
4. Katz, B. (1969) The Release of Neural Transmitter Substances , Liverpool University Press, Liverpool, UK
5. Augustine, G. J., Charlton, M. P., and Smith, S. J. (1987) Annu. Rev. Neurosci. 10, 633-693[CrossRef][Medline] [Order article via Infotrieve]
6. Geppert, M., Goda, Y., Hammer, R. E., Li, C., Rosahl, T. W., Stevens, C. F., and Sudhof, T. C. (1994) Cell 79, 717-727[Medline] [Order article via Infotrieve]
7. Yoshihara, M., and Littleton, J. T. (2002) Neuron 36, 897-908[Medline] [Order article via Infotrieve]
8. Perin, M. S., Brose, N., Jahn, R., and Sudhof, T. C. (1991) J. Biol. Chem. 266, 623-629[Abstract/Free Full Text]
9. Brose, N., Petrenko, A. G., Sudhof, T. C., and Jahn, R. (1992) Science 256, 1021-1025[Medline] [Order article via Infotrieve]
10. Augustine, G. J. (2001) Curr. Opin. Neurobiol. 11, 320-326[CrossRef][Medline] [Order article via Infotrieve]
11. Tucker, W. C., and Chapman, E. R. (2002) Biochem. J. 366, 1-13[Medline] [Order article via Infotrieve]
12. Li, C., Ullrich, B., Zhang, J. Z., Anderson, R. G., Brose, N., and Sudhof, T. C. (1995) Nature 375, 594-599[CrossRef][Medline] [Order article via Infotrieve]
13. Chapman, E. R., Hanson, P. I., An, S., and Jahn, R. (1995) J. Biol. Chem. 270, 23667-23671[Abstract/Free Full Text]
14. Zhang, X., Kim-Miller, M. J., Fukuda, M., Kowalchyk, J. A., and Martin, T. F. (2002) Neuron 34, 599-611[Medline] [Order article via Infotrieve]
15. McMahon, H. T., Missler, M., Li, C., and Sudhof, T. C. (1995) Cell 83, 111-119[Medline] [Order article via Infotrieve]
16. Sollner, T., Bennett, M. K., Whiteheart, S. W., Scheller, R. H., and Rothman, J. E. (1993) Cell 75, 409-418[Medline] [Order article via Infotrieve]
17. Hayashi, T., McMahon, H., Yamasaki, S., Binz, T., Hata, Y., Sudhof, T. C., and Niemann, H. (1994) EMBO J. 13, 5051-5061[Abstract]
18. Osborne, S. L., Herreros, J., Bastiaens, P. I., and Schiavo, G. (1999) J. Biol. Chem. 274, 59-66[Abstract/Free Full Text]
19. Schiavo, G., Gu, Q. M., Prestwich, G. D., Sollner, T. H., and Rothman, J. E. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 13327-13332[Abstract/Free Full Text]
20. Schiavo, G., Stenbeck, G., Rothman, J. E., and Sollner, T. H. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 997-1001[Abstract/Free Full Text]
21. Chen, D., Minger, S. L., Honer, W. G., and Whiteheart, S. W. (1999) Brain Res. 831, 11-24[CrossRef][Medline] [Order article via Infotrieve]
22. Fasshauer, D., Antonin, W., Subramaniam, V., and Jahn, R. (2002) Nat. Struct. Biol. 9, 144-151[CrossRef][Medline] [Order article via Infotrieve]
23. Steinberg, T. H., Jones, L. J., Haugland, R. P., and Singer, V. L. (1996) Anal. Biochem. 239, 223-237[CrossRef][Medline] [Order article via Infotrieve]
24. Perin, M. S., Fried, V. A., Mignery, G. A., Jahn, R., and Sudhof, T. C. (1990) Nature 345, 260-263[CrossRef][Medline] [Order article via Infotrieve]
25. Fernandez, I., Arac, D., Ubach, J., Gerber, S. H., Shin, O., Gao, Y., Anderson, R. G., Sudhof, T. C., and Rizo, J. (2001) Neuron 32, 1057-1069[Medline] [Order article via Infotrieve]
26. Bennett, M. K., Calakos, N., and Scheller, R. H. (1992) Science 257, 255-259[Medline] [Order article via Infotrieve]
27. Hu, K., Carroll, J., Fedorovich, S., Rickman, C., Sukhodub, A., and Davletov, B. (2002) Nature 415, 646-650[CrossRef][Medline] [Order article via Infotrieve]
28. Reist, N. E., Buchanan, J., Li, J., DiAntonio, A., Buxton, E. M., and Schwarz, T. L. (1998) J. Neurosci. 18, 7662-7673[Abstract/Free Full Text]
29. Garcia, E. P., McPherson, P. S., Chilcote, T. J., Takei, K., and De Camilli, P. (1995) J. Cell Biol. 129, 105-120[Abstract]
30. Gerona, R. R., Larsen, E. C., Kowalchyk, J. A., and Martin, T. F. (2000) J. Biol. Chem. 275, 6328-6336[Abstract/Free Full Text]
31. Wu, M. N., Fergestad, T., Lloyd, T. E., He, Y., Broadie, K., and Bellen, H. J. (1999) Neuron 23, 593-605[Medline] [Order article via Infotrieve]
32. Nalefski, E. A., and Falke, J. J. (1996) Protein Sci. 5, 2375-2390[Abstract/Free Full Text]
33. Duncan, R. R., Shipston, M. J., and Chow, R. H. (2000) Biochimie (Paris) 82, 421-426
34. Sudhof, T. C. (2002) J. Biol. Chem. 277, 7629-7632[Free Full Text]
35. Mackler, J. M., Drummond, J. A., Loewen, C. A., Robinson, I. M., and Reist, N. E. (2002) Nature 418, 340-344[CrossRef][Medline] [Order article via Infotrieve]
36. Robinson, I. M., Ranjan, R., and Schwarz, T. L. (2002) Nature 418, 336-340[CrossRef][Medline] [Order article via Infotrieve]
37. Fernandez-Chacon, R., Shin, O. H., Konigstorfer, A., Matos, M. F., Meyer, A. C., Garcia, J., Gerber, S. H., Rizo, J., Sudhof, T. C., and Rosenmund, C. (2002) J. Neurosci. 22, 8438-8446[Abstract/Free Full Text]


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.